{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:37:40Z","timestamp":1788824260588,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T00:00:00Z","timestamp":1681084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T00:00:00Z","timestamp":1681084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Changzhou Science and Technology Program","award":["CJ20220110"],"award-info":[{"award-number":["CJ20220110"]}]},{"name":"Science and Technology Support (Social Development) Project of Bureau of Science and Technology of Changzhou","award":["CE20215024"],"award-info":[{"award-number":["CE20215024"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The monocyte-to-lymphocyte ratio (MLR) is considered as a new inflammation marker. This study was aimed to investigate the prognostic value of MLR for all-cause mortality and new-onset cardiovascular disease (CVD) events in peritoneal dialysis (PD) patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study enrolled patients receiving PD treatment for \u2009\u2265\u20093\u00a0months. Baseline characteristics were obtained within 1\u00a0week before PD catheterization. The receiver operating characteristic curve analysis was conducted to determine the optimal cut-off value of MLR. The Kaplan\u2013Meier curve estimated the cumulative survival rate and new CVD free survival rate. Univariate and multivariate Cox regression models were preformed to investigate the association between MLR and clinical outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 369 PD patients participated in this study. During a median follow-up period of 32.83\u00a0months, 65 patients (24.2%) died, and 141 patients (52.4%) occurred new-onset CVD events. The Kaplan\u2013Meier curve revealed that survival rate in high MLR group (MLR \u2009&gt;\u20090.2168) was significantly lower than in low MLR group (<jats:italic>P<\/jats:italic>\u2009=\u20090.008). Patients in high MLR group were more likely to experience CVD events (<jats:italic>P<\/jats:italic>\u2009=\u20090.002). Even after adjustment of traditional risk factors, including age, diabetes mellitus, CVD history, smoking, hyperlipidemia, high MLR remained an independent predictor of all-cause mortality [hazard ration (HR)\u2009=\u20092.518, 95% confidence intervals (CI)\u2009=\u20091.020\u20136.214, <jats:italic>P<\/jats:italic>\u2009=\u20090.045] and new-onset CVD events (HR\u2009=\u20091.815, 95% CI\u2009=\u20091.157\u20132.849, <jats:italic>P<\/jats:italic>\u2009=\u20090.010).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study suggested that high MLR was significantly and independently associated with all-cause mortality and CVD events in PD patients. The MLR is an inexpensive and straightforward indicator to reflect systemic inflammation status and help clinicians improve PD management.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40001-023-01073-y","type":"journal-article","created":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T10:02:35Z","timestamp":1681120955000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["The prognostic value of monocyte-to-lymphocyte ratio in peritoneal dialysis patients"],"prefix":"10.1186","volume":"28","author":[{"given":"Yan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,10]]},"reference":[{"issue":"2","key":"1073_CR1","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.semnephrol.2011.01.005","volume":"31","author":"AY Wang","year":"2011","unstructured":"Wang AY. Consequences of chronic inflammation in peritoneal dialysis. Semin Nephrol. 2011;31(2):159\u201371.","journal-title":"Semin Nephrol"},{"issue":"1","key":"1073_CR2","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.semnephrol.2016.10.007","volume":"37","author":"PK Li","year":"2017","unstructured":"Li PK, Ng JK, Mcintyre CW. Inflammation and peritoneal dialysis. Semin Nephrol. 2017;37(1):54\u201365.","journal-title":"Semin Nephrol"},{"issue":"5","key":"1073_CR3","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.ajkd.2003.07.016","volume":"42","author":"K Kalantar-Zadeh","year":"2003","unstructured":"Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD. Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis. 2003;42(5):864\u201381.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"1073_CR4","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1093\/ndt\/gfh143","volume":"19","author":"K Kalantar-Zadeh","year":"2004","unstructured":"Kalantar-Zadeh K, Kopple JD, Humphreys MH, Block G. Comparing outcome predictability of markers of malnutrition-inflammation complex syndrome in haemodialysis patients. Nephrol Dial Transplant. 2004;19(6):1507\u201319.","journal-title":"Nephrol Dial Transplant"},{"key":"1073_CR5","doi-asserted-by":"publisher","first-page":"110963","DOI":"10.1016\/j.nut.2020.110963","volume":"79\u201380","author":"Y Yang","year":"2020","unstructured":"Yang Y, Zhou H, Zhang P, Chao W, Zou Y, Yang M. Evaluation of objective nutritional indexes as predictors of worse outcomes in peritoneal dialysis patients. Nutrition. 2020;79\u201380:110963.","journal-title":"Nutrition"},{"issue":"15","key":"1073_CR6","first-page":"1833","volume":"291","author":"U Ravnskov","year":"2004","unstructured":"Ravnskov U. Inflammation, cholesterol levels, and risk of mortality among patients receiving dialysis. JAMA. 2004;291(15):1833\u20134.","journal-title":"JAMA"},{"key":"1073_CR7","doi-asserted-by":"publisher","first-page":"9852507","DOI":"10.1155\/2020\/9852507","volume":"2020","author":"Y Wen","year":"2020","unstructured":"Wen Y, Zhan X, Wang N, Peng F, Feng X, Wu X. Monocyte\/lymphocyte ratio and cardiovascular disease mortality in peritoneal dialysis patients. Mediators Inflamm. 2020;2020:9852507.","journal-title":"Mediators Inflamm"},{"key":"1073_CR8","doi-asserted-by":"publisher","first-page":"4634736","DOI":"10.1155\/2020\/4634736","volume":"2020","author":"Y Zeng","year":"2020","unstructured":"Zeng Y, Chen Z, Chen Q, et al. Neutrophil to lymphocyte ratio predicts adverse cardiovascular outcome in peritoneal dialysis patients younger than 60 years old. Mediators Inflamm. 2020;2020:4634736.","journal-title":"Mediators Inflamm"},{"key":"1073_CR9","doi-asserted-by":"publisher","first-page":"106063","DOI":"10.1016\/j.intimp.2019.106063","volume":"78","author":"T Chen","year":"2020","unstructured":"Chen T, Yang M. Platelet-to-lymphocyte ratio is associated with cardiovascular disease in continuous ambulatory peritoneal dialysis patients. Int Immunopharmacol. 2020;78:106063.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"1073_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.tranon.2016.10.006","volume":"10","author":"J Xiang","year":"2017","unstructured":"Xiang J, Zhou L, Li X, et al. Preoperative monocyte-to-lymphocyte ratio in peripheral blood predicts stages, metastasis, and histological grades in patients with ovarian cancer. Transl Oncol. 2017;10(1):33\u20139.","journal-title":"Transl Oncol"},{"issue":"31","key":"1073_CR11","doi-asserted-by":"publisher","first-page":"4639","DOI":"10.3748\/wjg.v26.i31.4639","volume":"26","author":"K Jakubowska","year":"2020","unstructured":"Jakubowska K, Koda M, Grudzi\u0144ska M, Ka\u0144czuga-Koda L, Famulski W. Monocyte-to-lymphocyte ratio as a prognostic factor in peripheral whole blood samples of colorectal cancer patients. World J Gastroenterol. 2020;26(31):4639\u201355.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"1073_CR12","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/hdi.12549","volume":"22","author":"F Xiang","year":"2018","unstructured":"Xiang F, Chen R, Cao X, et al. Monocyte\/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study. Hemodial Int. 2018;22(1):82\u201392.","journal-title":"Hemodial Int"},{"issue":"5","key":"1073_CR13","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/ki.2010.462","volume":"79","author":"LA Stevens","year":"2011","unstructured":"Stevens LA, Claybon MA, Schmid CH, et al. Evaluation of the chronic kidney disease epidemiology collaboration equation for estimating the glomerular filtration rate in multiple ethnicities. Kidney Int. 2011;79(5):555\u201362.","journal-title":"Kidney Int"},{"issue":"11","key":"1073_CR14","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1681\/ASN.2016010112","volume":"27","author":"R Mehrotra","year":"2016","unstructured":"Mehrotra R, Ol Devuyst, Davies SJ, Johnson DW. The current state of peritoneal dialysis. J Am Soc Nephrol. 2016;27(11):3238\u201352.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"1073_CR15","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/ndt\/gfv295","volume":"31","author":"MW van de Luijtgaarden","year":"2016","unstructured":"van de Luijtgaarden MW, Jager KJ, Segelmark M, et al. Trends in dialysis modality choice and related patient survival in the ERA-EDTA registry over a 20-year period. Nephrol Dial Transplant. 2016;31(1):120\u20138.","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"1073_CR16","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1093\/ndt\/gfr674","volume":"27","author":"K Yeates","year":"2012","unstructured":"Yeates K, Zhu N, Vonesh E, Trpeski L, Blake P, Fenton S. Hemodialysis and peritoneal dialysis are associated with similar outcomes for end-stage renal disease treatment in Canada. Nephrol Dial Transplant. 2012;27(9):3568\u201375.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"1073_CR17","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1002\/cphy.c120028","volume":"3","author":"JD Imig","year":"2013","unstructured":"Imig JD, Ryan MJ. Immune and inflammatory role in renal disease. Compr Physiol. 2013;3(2):957\u201376.","journal-title":"Compr Physiol"},{"issue":"1","key":"1073_CR18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/ndt\/gfx222","volume":"33","author":"C Cafiero","year":"2018","unstructured":"Cafiero C, Gigante M, Brunetti G, et al. Inflammation induces osteoclast differentiation from peripheral mononuclear cells in chronic kidney disease patients: crosstalk between the immune and bone systems. Nephrol Dial Transplant. 2018;33(1):65\u201375.","journal-title":"Nephrol Dial Transplant"},{"key":"1073_CR19","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.3389\/fimmu.2018.02845","volume":"9","author":"SD Naicker","year":"2018","unstructured":"Naicker SD, Cormican S, Griffin TP, et al. Chronic kidney disease severity is associated with selective expansion of a distinctive intermediate monocyte subpopulation. Front Immunol. 2018;9:2845.","journal-title":"Front Immunol"},{"key":"1073_CR20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.cca.2019.11.021","volume":"503","author":"M Zhang","year":"2020","unstructured":"Zhang M, Wang K, Zheng H, Zhao X, Xie S, Liu C. Monocyte lymphocyte ratio predicts the new-onset of chronic kidney disease: a cohort study. Clin Chim Acta. 2020;503:181\u20139.","journal-title":"Clin Chim Acta"},{"issue":"1","key":"1073_CR21","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12872-017-0507-4","volume":"17","author":"H Ji","year":"2017","unstructured":"Ji H, Li Y, Fan Z, et al. Monocyte\/lymphocyte ratio predicts the severity of coronary artery disease: a syntax score assessment. BMC Cardiovasc Disord. 2017;17(1):90.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"1073_CR22","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrcardio.2014.160","volume":"12","author":"PG Camici","year":"2015","unstructured":"Camici PG, d\u2019Amati G, Rimoldi O. Coronary microvascular dysfunction: mechanisms and functional assessment. Nat Rev Cardiol. 2015;12(1):48\u201362.","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"1073_CR23","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2174\/15701611113119990012","volume":"13","author":"E Araldi","year":"2015","unstructured":"Araldi E, Chamorro-Jorganes A, van Solingen C, Fernandez-Hernando C, Suarez Y. Therapeutic potential of modulating micrornas in atherosclerotic vascular disease. Curr Vasc Pharmacol. 2015;13(3):291\u2013304.","journal-title":"Curr Vasc Pharmacol"},{"issue":"10","key":"1073_CR24","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/j.jacc.2005.02.054","volume":"45","author":"BD Horne","year":"2005","unstructured":"Horne BD, Anderson JL, John JM, et al. Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol. 2005;45(10):1638\u201343.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"1073_CR25","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1097\/01.ASN.0000070071.57901.B3","volume":"14","author":"AY Wang","year":"2003","unstructured":"Wang AY, Woo J, Lam CW, et al. Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients? J Am Soc Nephrol. 2003;14(7):1871\u20139.","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"1073_CR26","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1681\/ASN.2005030226","volume":"16","author":"PT Vlagopoulos","year":"2005","unstructured":"Vlagopoulos PT, Tighiouart H, Weiner DE, et al. Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: the impact of chronic kidney disease. J Am Soc Nephrol. 2005;16(11):3403\u201310.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"1073_CR27","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s10157-013-0847-z","volume":"18","author":"D Nosratola Vaziri","year":"2014","unstructured":"Nosratola Vaziri D. Role of dyslipidemia in impairment of energy metabolism, oxidative stress, inflammation and cardiovascular disease in chronic kidney disease. Clin Exp Nephrol. 2014;18(2):265\u20138.","journal-title":"Clin Exp Nephrol"},{"issue":"14","key":"1073_CR28","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1056\/NEJMoa050461","volume":"352","author":"JC LaRosa","year":"2005","unstructured":"LaRosa JC, Grundy SM, Waters DD, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med. 2005;352(14):1425\u201335.","journal-title":"N Engl J Med"},{"issue":"1","key":"1073_CR29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12944-020-01240-8","volume":"19","author":"T Lin","year":"2020","unstructured":"Lin T, Xia X, Yu J, et al. The predictive study of the relation between elevated low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and mortality in peritoneal dialysis. Lipids Health Dis. 2020;19(1):51.","journal-title":"Lipids Health Dis"},{"issue":"3","key":"1073_CR30","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3390\/nu10030300","volume":"10","author":"YC Lin","year":"2018","unstructured":"Lin YC, Lin YC, Peng CC, et al. Effects of cholesterol levels on mortality in patients with long-term peritoneal dialysis based on residual renal function. Nutrients. 2018;10(3):300.","journal-title":"Nutrients"},{"issue":"1","key":"1073_CR31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000503632","volume":"6","author":"N Stepanova","year":"2020","unstructured":"Stepanova N, Vi Driianska, Savchenko S. Dyslipidemia and intraperitoneal inflammation axis in peritoneal dialysis patients: a cross-sectional pilot study. Kidney Dis (Basel). 2020;6(1):35\u201342.","journal-title":"Kidney Dis (Basel)"},{"issue":"2","key":"1073_CR32","doi-asserted-by":"publisher","first-page":"243","DOI":"10.5301\/jn.5000169","volume":"26","author":"W Zhang","year":"2013","unstructured":"Zhang W, He J, Zhang F, et al. Prognostic role of C-reactive protein and interleukin-6 in dialysis patients: a systematic review and meta-analysis. J Nephrol. 2013;26(2):243\u201353.","journal-title":"J Nephrol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01073-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-023-01073-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01073-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T10:06:02Z","timestamp":1681121162000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-023-01073-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,10]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1073"],"URL":"https:\/\/doi.org\/10.1186\/s40001-023-01073-y","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,10]]},"assertion":[{"value":"13 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients signed informed consent. The study was in keeping with the principles of the Declaration of Helsinki and with the approval of the Ethics Committee at the Third Affiliated Hospital of Soochow University, China (Registration Number:19\/2019).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval for consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"152"}}